The 3360.HK stock opened intraday at HKD 7.44 after Far East Horizon posted earnings on 06 Mar 2026. The company reported EPS of HKD 0.98 and a trailing P/E of 7.59, figures that drove active trading volume of 14,976,093 shares. We focus on how the results connect to valuation, sector peers and a model forecast that implies material upside.

Earnings snapshot and immediate metrics for 3360.HK stock

Far East Horizon reported results tied to its finance and industrial segments on 06 Mar 2026. Reported EPS 0.98 and trailing PE 7.59 stand against a market price of HKD 7.44. Day range is HKD 7.41–7.71 with intraday change -1.20%, reflecting mixed investor reaction to margins and asset quality data.

Intraday market reaction and liquidity signals

Price moved from an open of HKD 7.59 to a last trade of HKD 7.44, down HKD 0.09 or -1.20%. Volume was 14,976,093, versus average volume 9,594,325, giving a relative volume of 1.56. Higher turnover shows traders digesting the earnings; the year high is HKD 8.54 and year low is HKD 5.73, keeping the stock within a moderate range.

Valuation, dividend and balance sheet highlights

Far East Horizon trades at PB 0.59 and price/sales 0.82, suggesting value relative to many financial peers. The company yields 7.39% (dividend per share HKD 0.49) with a payout ratio near 54.00%. Debt metrics are heavy: debt/equity reads 5.22, and debt/assets 0.73, which increases financing risk despite solid book value per share HKD 12.90.

Technical picture and sector context for 3360.HK stock

Momentum indicators show pressure: RSI 38.37 and MACD histogram -0.04, while CCI at -176.42 signals oversold conditions. The Financial Services sector YTD performance is slightly negative; sector average PE is about 15.31, so Far East Horizon trades below sector multiples. Short-term technical setup favours cautious entries above HKD 7.78 (BB middle).

Meyka AI grade and model forecast for 3360.HK

Meyka AI rates 3360.HK with a score of 64.25 out of 100 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 12‑month price of HKD 9.86, versus the current HKD 7.44, implying 32.53% upside. These grades are model outputs and not guarantees; they are not financial advice.

Price targets, risks and trading considerations

Near-term reference targets: monthly HKD 8.42, quarter HKD 8.98, and 12‑month HKD 9.86 from model outputs. Upside catalysts include faster lease loan growth and stable hospital operations. Downside risks are high leverage, interest coverage constraints, and slower China credit demand. Traders should monitor liquidity, expiry of earnouts, and changes to debt servicing metrics.

Final Thoughts

Key takeaways for the 3360.HK stock after the 06 Mar 2026 earnings release: the company reported EPS HKD 0.98 and trades at a modest PE 7.59, which supports a valuation case for income investors. Intraday flow shows heavy volume 14,976,093 and a small pullback -1.20%, while technicals (RSI 38.37) point to oversold momentum. Meyka AI’s forecast model projects HKD 9.86 in 12 months, an implied upside of 32.53% versus the current HKD 7.44. That projection assumes steady lease growth and controlled credit costs. Balance-sheet leverage (debt/equity 5.22) is the main structural risk and could compress multiples if credit conditions tighten. For income-focused investors, the 7.39% yield is attractive, but risk-tolerant investors should weigh leverage and sector cyclicality. We summarize the stance as cautious: the stock offers meaningful upside in our model, balanced by elevated leverage and earnings sensitivity. Meyka AI provides this as data-driven market analysis only, not investment advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.